Recombinant RSV (Palivizumab Biosimilar) 抗体
Quick Overview for Recombinant RSV (Palivizumab Biosimilar) 抗体 (ABIN7200664)
抗原
抗体类型
适用
宿主
克隆类型
标记
应用范围
-
-
原理
- Palivizumab Biosimilar, RSV Monoclonal Antibody
-
特异性
- The monoclonal antibody palivizumab biosimilar specifically binds to an epitope in the A antigenic site of the F protein of RSV (respiratory syncytial virus).
-
产品特性
- Recombinant Humanized IgG1 Monoclonal Antibody.
-
纯化方法
- Protein A affinity column
-
纯度
- > 95% by SDS-PAGE under reducing conditions and HPLC.
-
过滤
- 0.2 μm filtered
-
内毒素水平
- < 1 EU per 1 mg of the protein by the LAL method.
-
免疫原
- The monoclonal antibody palivizumab biosimilar was produced in the palivizumab biosimilar CHO stable cell line.
-
亚型
- IgG1 kappa
-
-
-
-
应用备注
- ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by palivizumab.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 mg/mL
-
缓冲液
- PBS, pH 7.4, no stabilizers or preservatives.
-
储存液
- Without preservative
-
注意事项
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied.
-
有效期
- 12 months
-
-
- RSV (Palivizumab Biosimilar)
-
物质类
- Biosimilar
-
背景
- Palivizumab, a humanized anti-RSV (respiratory syncytial virus) monoclonal antibody, targets an epitope in the A antigenic site of the F protein of RSV, inhibiting its entry into the cell and thereby preventing infection.
抗原
-